Chronic bronchitis patho
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Loading Image
Reading File
Finding Sources
Finding Sources
Reading File
Loading Image
Finding Sources
I have all the information needed for a comprehensive answer. Let me now compose it.
Chronic Bronchitis - Pathophysiology
Definition
Chronic bronchitis is defined clinically (not anatomically) as a persistent productive cough lasting at least 3 months in at least 2 consecutive years, with no other identifiable cause. It is distinct from emphysema, which is defined anatomically.
- Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 637
Etiology / Triggers
The initiating factor is exposure to noxious inhaled substances. Key causes:
- Cigarette smoke - by far the most common (90% of affected patients are smokers, typically >40 pack-years)
- Air pollutants: sulfur dioxide, nitrogen dioxide, grain dust, cotton dust, silica
Pathogenesis
The pathogenesis involves four converging mechanisms:
1. Mucus Hypersecretion (the hallmark)
- The earliest and defining feature is hypersecretion of mucus in the large airways
- Driven by:
- Enlargement of submucosal mucous glands in the trachea and bronchi (assessed by the Reid index)
- Goblet cell hyperplasia in small bronchi and bronchioles (these normally have few/no goblet cells)
- Mediators involved include histamine and IL-13 (released from T cells stimulated by tobacco smoke)
- Neutrophil elastase expression is also increased by tobacco smoke
2. Acquired CFTR Dysfunction
- Smoking causes acquired dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR)
- This leads to secretion of abnormally dehydrated, concentrated mucus - worsening mucociliary clearance
- Oxidative stress further induces mucus hyperconcentration through this pathway
- The two key secreted mucins are MUC5B and MUC5AC; in CB, MUC5AC is hyperseccreted, though decreased MUC5B may dominate in some patients
3. Inflammation
- Inhaled irritants cause cellular damage, triggering both acute and chronic inflammatory responses
- Inflammatory infiltrate: neutrophils, lymphocytes, and macrophages (notably, NO eosinophils - this distinguishes it from asthma)
- Long-standing inflammation in small airways (<2-3 mm) causes peribronchial fibrosis → chronic airway obstruction
- Cigarette smoke also impairs ciliary function, preventing mucus clearance and increasing infection risk
4. Infection
- Infection does not initiate chronic bronchitis
- It has a secondary role: maintaining and sustaining inflammation, and critically triggering acute exacerbations
- Common organisms: Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis
Morphology (Gross and Microscopic)
Gross findings:
- Hyperemia, swelling, and edema of bronchial mucosa
- Mucinous or mucopurulent secretions - sometimes forming heavy casts that fill bronchi and bronchioles
Microscopic findings:
| Feature | Detail |
|---|---|
| Mucous gland enlargement | Most striking change; affects trachea and large bronchi |
| Reid Index increased | Normally 0.4; ratio of mucous gland layer thickness to wall thickness (epithelium to cartilage); elevated in proportion to severity and duration |
| Goblet cell hyperplasia/metaplasia | In small bronchi and bronchioles |
| Chronic inflammation | Predominantly lymphocytes and macrophages; neutrophils in exacerbations |
| Bronchiolar wall thickening | Due to smooth muscle hypertrophy + ECM deposition + peribronchial fibrosis |
| Squamous metaplasia and dysplasia | From mutagenic/irritant effects of tobacco smoke |
| Bronchiolitis obliterans (severe cases) | Complete luminal obliteration due to fibrosis |
- Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 637
- Robbins & Kumar Basic Pathology, p. 449
Mechanism of Airflow Obstruction
A key concept: the mucus hypersecretion involves large airways, but the airflow obstruction results from small airway disease (chronic bronchiolitis):
Mucous plugging of bronchiolar lumen + inflammation + bronchiolar wall fibrosis → luminal narrowing → obstructive pattern (FEV1/FVC <0.7)
This explains why early chronic bronchitis can exist without airflow obstruction - it becomes obstructive only once small airway disease is established.
Clinical Phenotype: "Blue Bloater"
Patients with dominant chronic bronchitis are classically the "blue bloater" phenotype (contrasted with "pink puffer" emphysema):
| Feature | Chronic Bronchitis (Blue Bloater) | Emphysema (Pink Puffer) |
|---|---|---|
| Age at onset | 40-45 years | 50-75 years |
| Dyspnea | Mild, late | Severe, early |
| Cough | Early; copious sputum | Late; scanty sputum |
| Respiratory failure | Early, periodic | End-stage |
| Cor pulmonale | Common | Uncommon (end-stage) |
| Hypoxemia/cyanosis | Present ("blue") | Relatively preserved |
The "blue" refers to hypoxemia with cyanosis; the "bloater" refers to cor pulmonale with peripheral edema from pulmonary hypertension.
Consequences of Long-Standing Disease
- Progressive small airway fibrosis → COPD
- Hypoxemia → pulmonary vasoconstriction → pulmonary hypertension
- Pulmonary hypertension → right ventricular hypertrophy → cor pulmonale
- Squamous metaplasia/dysplasia → increased lung cancer risk (change in cough pattern in a smoker must prompt evaluation)
Sources: Robbins, Cotran & Kumar Pathologic Basis of Disease (9th ed.), pp. 636-639 | Robbins & Kumar Basic Pathology, pp. 448-450 | Murray & Nadel's Textbook of Respiratory Medicine
This is a shared conversation. Sign in to Orris to start your own chat.